Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Monograph series

Mitochondrial and metabolic cofactors

Mitochondrial-derived peptides, cardiolipin-binding agents, redox cofactors and enzyme inhibitors.

Monographs in this series

5 documents
  • CEI-MN-047Mitochondrial and metabolic cofactorsPreclinical only3 assessed outcomesversion 4.0

    NNMT methylates nicotinamide, diverting it from NAD+ salvage and generating 1-methylnicotinamide. Inhibiting NNMT is proposed to raise cellular NAD+ and to reduce adipocyte lipogenesis. In diet-induced obese mice, 5-amino-1MQ…

    Very low07 Dec 2025
  • CEI-MN-046Mitochondrial and metabolic cofactorsUnapproved, research supply3 assessed outcomesversion 1.3

    Glutathione is the dominant intracellular low-molecular-weight thiol and the cofactor of the glutathione peroxidase and S-transferase systems. Administered glutathione is largely degraded extracellularly by gamma-glutamyl…

    Low06 May 2026
  • CEI-MN-043Mitochondrial and metabolic cofactorsUnapproved, research supply4 assessed outcomesversion 1.0

    MOTS-c is described as a mitochondrial-encoded regulator of metabolic homeostasis that acts through the folate one-carbon cycle to raise 5-aminoimidazole-4-carboxamide ribonucleotide and thereby activate AMP-activated protein…

    Very low20 Aug 2025
  • CEI-MN-045Mitochondrial and metabolic cofactorsUnapproved, research supply4 assessed outcomesversion 2.1

    NAD+ is the central redox coenzyme of intermediary metabolism and the substrate of the sirtuin and poly-ADP-ribose polymerase enzyme families. Tissue NAD+ declines with age in several species, which is the basis of interest in…

    Very low23 Aug 2026
  • CEI-MN-044Mitochondrial and metabolic cofactorsDiscontinued3 assessed outcomesversion 4.2

    Elamipretide binds cardiolipin in the inner mitochondrial membrane, stabilising cristae curvature and the assembly of electron-transport-chain supercomplexes, and reducing cytochrome-c peroxidase activity. The result in…

    Moderate17 Apr 2025
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.